Hanliang Zhu

Papers

Total Citations

H-Index

About

Hanliang Zhu is a leading researcher in cord blood stem cell processing and cryopreservation, with a focus on developing and validating automated systems to improve the efficiency and safety of hematopoietic stem cell transplantation. Their most notable contribution is the landmark validation study of the AXP™ AutoXpress™ Platform, which demonstrated the platform’s ability to achieve high mononuclear cell recovery rates while maintaining sterility and reproducibility. This work, cited 5 times, established a critical benchmark for automated cord blood processing, reducing manual handling errors and enhancing clinical scalability. Zhu’s research directly addresses the need for standardized, closed-system technologies in regenerative medicine, enabling more reliable stem cell banking for transplant therapies. Their achievements include advancing the integration of microprocessor-controlled devices and sterile disposable bag sets, supported by XpressTRAK™ software, to streamline workflows in cord blood banks. By bridging engineering and clinical application, Zhu has helped shape modern protocols for cord blood processing, making stem cell therapies more accessible and consistent. Their work remains foundational for researchers and clinicians seeking to optimize cell recovery and quality in transplantation medicine.